Global Research – by Ellen Brown
More than 100 companies are competing to be first in the race to get a COVID-19 vaccine to market. It’s a race against time, not because the death rate is climbing but because it is falling – to the point where there could soon be too few subjects to prove the effectiveness of the drug.
Continue reading “When Profits and Politics Drive Science: The Hazards of Rushing a Vaccine at “Warp Speed””